Why the study?
Does the number of morbidities affect depression prevalence and health-care costs in a population-based cohort?
Does the number of morbidities affect depression prevalence and health-care costs in a population-based cohort?
The number of morbidities is a stronger predictor of depression prevalence and healthcare costs than the specific type of comorbid diagnosis.
Multimorbidity count may better inform depression screening and cost projections than specific diagnoses; leaves open targeted intervention effects.
Depression prevalence and health-care costs are more strongly associated with the number of morbidities than the nature of the co-morbid diagnosis.
No takes yet. Share an insight, caveat, or question.
Bhattarai et al. (2012) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: